Loading clinical trials...

Efficacy of Short-message-based Re-education (SMRE) on Helicobacter Pylori Eradication | Clinical Trials | Clareo Health

UNKNOWNPHASE4

Efficacy of Short-message-based Re-education (SMRE) on Helicobacter Pylori Eradication

NCT02833623•Shandong University

View on ClinicalTrials.gov

Summary

Helicobacter pylori (H. pylori) is a pathogen that infects more than 50% of the human population, resulting in high healthcare costs worldwide. However, H. pylori eradication rate is low nowadays and patients's compliance is one of the most important effective factors.

Eligibility

Age

18 - 70 years

Sex

ALL

Healthy Volunteers

Yes

Inclusion Criteria

•outpatients aged 18-70 years
•confirmed diagnosis of H. pylori infection by at least one of the following methods: 13C-urea breath test, histology, rapid urease test or bacterial culture
•an intention of H. pylori eradication treatment and have written inform consent
•ability to read short messages on the mobile phone

Exclusion Criteria

•advanced chronic disease that would not allow the patient to complete the treatment or follow-up or attend visits
•allergy to any of the drugs used in this study
•previous Helicobacter Pylori eradication treatment
•pregnancy or breastfeeding (female participants with childbearing potential were required to use medically accepted contraception for the duration of the study)
•taking antibiotics or PPIs or bismuth salts within four weeks
•previous gastrointestinal surgery

Locations (1)

Department of Gastroenterology, Qilu Hospital, Shandong University

Jinan, Shandong, China

Key Dates

Start Date

October 1, 2016

Primary Completion Date

January 1, 2017

Completion Date

January 1, 2017

Last Updated

October 14, 2016

Enrollment

310

ESTIMATED participants

Conditions

Helicobacter Pylori Eradication Rate

Interventions

Short-message-based Re-education

BEHAVIORAL

conventional education

BEHAVIORAL

Contacts

Yanqing Li, MD,PhD

CONTACT

86-531-82169236 liyanqing@sdu.edu.cn

Modified Non-clarithromycin Triple Therapy in Eradicating Helicobacter Pylori

NCT02776371

Helicobacter Pylori Eradication Rate

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: October 14, 2016Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions